Two new international studies on HCV show elimination programs have high levels of engagement, treatment initiation, and cure rates.
Andrew D. Bowser
For patients infected with hepatitis C virus who do not respond to direct-acting antiviral agents, results of a new study could mean a much brighter future.
These 5 questions on HCV infection are a quick brush-up on disease basics and treatment.
The current study was one of the largest analyses to date of black participants receiving all-oral DAA treatment.
HCV screening of baby boomers seen in a suburban emergency department found remarkably high seropositivity rates, say authors of a new study.
This new quiz on hepatitis C tests what you know about mother-to-child transmission, testing at-risk populations, optimal regimens for your sickest patients, and more.
RA can be managed in primary care but comes with unique challenges. Here, strategies outlined at the ACP Internal Medicine Meeting 2018.
Five tips for PCPs on managing treatment-resistant depression were offered at the ACP Internal Medicine Meeting 2018 today. Patient Care offers a summary.
Black and Hispanic boomers had lower odds of HCV screening between 2013-2015, as did female and older members of the 1945-1965 cohort.
The recently-approved HCV treatment produced SVR rates of 95% or greater and discontinuation rates for AEs were extremely low.